ETHZilla Corp — Director's Dealing 2023

Dec 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2023-12-15

Reporting Person: Feldmann Marc (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-15	Common Stock	S	25000	$0.188	Disposed	115497	Direct

Footnotes

F1: Effective on December 15, 2023, Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, sold 25,000 shares of common stock of the Issuer to Dr. James N. Woody, the Chief Executive Officer of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date.